HSPH1 and neoplasm: T cells activated by iDCs can produce cytokines which inhibit the expression of HSPs (HSP27, HSP70, HSP90, HSP105 and HSF1), as well as promoting tumor apoptosis and synergistically amplifying the antitumor effect of low temperature photothermal treatment (42–45°C).